Tole Soumitra, Dhir Priya, Pugi Jakob, Drury Luke J, Butchart Sheila, Fantauzzi Michelle, Langer Jacob C, Baker Jillian M, Blanchette Victor S, Kirby-Allen Melanie, Carcao Manuel D
Department of Paediatrics, Division of Haematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Paediatrics, Division of Haematology/Oncology, Children's Hospital, London Health Sciences Centre, London, Ontario, Canada.
Br J Haematol. 2020 Nov;191(3):486-496. doi: 10.1111/bjh.16750. Epub 2020 May 20.
Hereditary spherocytosis (HS) is a common inherited haemolytic anaemia attributed to disturbances in five different red cell membrane proteins. We performed a retrospective study of 166 children with HS and describe the clinical phenotype according to the genotype. In 160/166 (97%) children with HS a disease-causing mutation was identified. Pathogenic variants in ANK1, SPTB, SLC4A1 and SPTA1 were found in 49%, 33%, 13% and 5% of patients. Children with SLC4A1-HS had the mildest phenotype, showing the highest haemoglobin (P < 0·001), lowest reticulocyte counts (P < 0·001) and lowest unconjugated bilirubin levels (P = 0·006), and none required splenectomy in childhood (P < 0·001). Conversely, children with autosomal recessive SPTA1-HS had the most severe clinical phenotype, with almost all patients undergoing splenectomy in early childhood. Patients with ANK1 and SPTB variants showed a similar clinical phenotype. Within each gene, variant type or location did not predict disease severity or likelihood of splenectomy. Among patients with a genetic diagnosis, 47 (29%) underwent splenectomy (23 partial; 24 total) while 57 (36%) underwent cholecystectomy. Total splenectomy led to greater improvements in haemoglobin (P = 0·02). Select use of genetic testing (especially in patients without a family history) may help predict clinical phenotype in childhood and guide family counselling.
遗传性球形红细胞增多症(HS)是一种常见的遗传性溶血性贫血,归因于五种不同红细胞膜蛋白的紊乱。我们对166例HS患儿进行了一项回顾性研究,并根据基因型描述了临床表型。在166例HS患儿中,有160例(97%)鉴定出致病突变。ANK1、SPTB、SLC4A1和SPTA1的致病变异分别在49%、33%、13%和5%的患者中发现。SLC4A1-HS患儿的表型最轻微,血红蛋白水平最高(P<0.001),网织红细胞计数最低(P<0.001),未结合胆红素水平最低(P=0.006),且儿童期均无需行脾切除术(P<0.001)。相反,常染色体隐性SPTA1-HS患儿的临床表型最严重,几乎所有患者在幼儿期均接受了脾切除术。ANK1和SPTB变异的患者表现出相似的临床表型。在每个基因中,变异类型或位置均不能预测疾病严重程度或脾切除术的可能性。在进行基因诊断的患者中,47例(29%)接受了脾切除术(23例部分切除;24例全切除),57例(36%)接受了胆囊切除术。全脾切除术使血红蛋白有更大改善(P=0.02)。选择性使用基因检测(尤其是在无家族史的患者中)可能有助于预测儿童期的临床表型并指导家庭咨询。